Cytogel Pharma Announces Equity Offering to Advance CYT-1010, A Transformative Pain Solution
DARIEN, CT, UNITED STATES, November 20, 2025 /EINPresswire.com/ -- Cytogel Pharma, a clinical-stage biopharmaceutical startup pioneering first-in-class endomorphin-based therapies, announced today that it is progressing its equity financing round to …